Table of Contents
Molecules, Volume 24, Issue 4 (February-2 2019)
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
- You may sign up for e-mail alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Cover Story (view full-size image) Cistanche tubulosa aqueous extract (CTE) is already used as a botanical prescription drug for [...] Read more. Cistanche tubulosa aqueous extract (CTE) is already used as a botanical prescription drug for treating dementia in China. Our previous studies reported that phenylethanoid glycosides (1-3) of CTE have anti-Alzheimer’s disease (AD) activity by inhibiting amyloid β peptide (Aβ) aggregation and deposition. Metal ions were recently considered a key factor closely related to Aβ aggregation. This study demonstrated that phenylethanoid glycosides would have iron chelating activity. Iron is the essential element in serum and the brain. CTE has a potential anti-AD activity targeting iron chelation-induced Aβ aggregation and deposition. In addition, we further proved that phenylethanoid glycosides would reach the brain. Active CTE component confirmation will be a great help for product quality control and bioavailability studies in the future. View this paper.